Status:

ACTIVE_NOT_RECRUITING

CREST: Capsular Repair During Hip Arthroscopy

Lead Sponsor:

Mayo Clinic

Conditions:

Hip Arthroscopy

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

Capsular REpair randomiSed controlled Trial (CREST) is a multi-center, randomized controlled trial with a sample size of 240 patients (120 patients in each group). The primary outcome measure is funct...

Detailed Description

Background Femoroacetabular impingement (FAI) is a well-described condition that causes hip pain in young to middle age adults. Cross sectional studies have estimated that the prevalence of hip imping...

Eligibility Criteria

Inclusion

  • Criteria: Inclusion Criteria:
  • Adults aged 18 to 50 (men or women)
  • Hip pain for greater than 3 months that has failed non-operative treatment (physical therapy, NSAIDS, rest)
  • FAI documented on X-Ray or Magnetic resonance imaging (MRI) or magnetic resonance arthrogram (MRA)
  • Intraoperative labral repair or intact labrum
  • Informed consent from the participant
  • Ability to comprehend and speak English and the study design.
  • Pre-operative exclusion criteria are the following:
  • Hypermobility/Ehlers-Danlos syndrome
  • Evidence of hip dysplasia (Center edge angle less than 20)
  • Previous surgery or trauma of the affected hip
  • Severe acetabular deformities such as circumferential labral ossification, acetabular protrusion20
  • Inflammatory/ autoimmune disease
  • Immunosuppressant medication
  • Significant medical co-morbidities such as uncontrolled diabetes, hypertension, congestive heart failure, etc.
  • Severe mental or physical disability requiring assistance in daily living
  • History of pediatric hip disease with previous operation (developmental dysplasia, Legg-Calve-Perthes, Slipped capital femoral epiphysis)
  • Presence of advanced hip osteoarthritis (Tonnis grade 2 or 3)18
  • Worker's compensation status
  • Intraoperative microfracture, or other procedure that would alter postoperative rehabilitation
  • Intraoperative labral debridement or labral reconstruction
  • Peri-trochanteric or deep gluteal space arthroscopy
  • Avascular necrosis
  • Intra-operative exclusion criteria are the following:
  • Labral debridement
  • Labral reconstruction
  • Poor quality capsular tissue
  • Hyperlaxity based on excessive subluxation of the joint greater than 2 cm with standard 50 pounds of traction
  • Concomitant procedures such as MFX and iliopsoas lengthening will be included

Exclusion

    Key Trial Info

    Start Date :

    November 7 2017

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2040

    Estimated Enrollment :

    250 Patients enrolled

    Trial Details

    Trial ID

    NCT03372564

    Start Date

    November 7 2017

    End Date

    December 1 2040

    Last Update

    April 24 2025

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Mayo Clinic in Arizona

    Scottsdale, Arizona, United States, 85259

    2

    American Hip Institute

    Westmont, Illinois, United States, 60559

    3

    Mayo Clinic in Rochester

    Rochester, Minnesota, United States, 55905